According to Zhitong Finance App, Xintian Pharmaceutical (002873.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved operating income of 332 million yuan, a year-on-year decrease of 7.39%; net profit attributable to shareholders of listed companies was 4.8614 million yuan, a year-on-year decrease of 15.69%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 3.9844 million yuan, an increase of 11.31% year on year; basic earnings per share were 0.0206 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.